Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Delayed-rectifier potassium channels are a diverse family of voltage-gated ion channels (Kv) that are essential for the repolarization phase of action potentials in neurons and cardiomyocytes (Source: StatPearls, 'Physiology, Potassium Channels'). They function by opening in response to membrane depolarization with a characteristic time delay, allowing K+ ions to exit the cell and restore the resting membrane potential (Source: UniProt, 'Voltage-gated potassium channel'). While dexmedetomidine is primarily a selective alpha-2 adrenergic receptor agonist, research indicates it acts as an off-target inhibitor of delayed-rectifier potassium currents, particularly at higher concentrations (Source: PubMed, PMID: 15575897). This inhibition can prolong the action potential duration and may contribute to the drug's complex electrophysiological effects, including potential bradycardia or altered sedative depth (Source: Journal of Neurosurgical Anesthesiology). These channels are also therapeutic targets for Class III anti-arrhythmic agents, and their dysfunction is linked to conditions such as Long QT syndrome and epilepsy (Source: NIH, 'Potassium Channels and Disease'). In the central nervous system, these channels regulate firing frequency and neurotransmitter release, making them critical for maintaining neural circuit stability.
Inhibition of the ion-conducting pore to reduce potassium efflux, thereby delaying cellular repolarization and extending the action potential duration.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Delayed-rectifier potassium channel (Kv channel) (Kv channel).